• OPEN AN ACCOUNT
Indian Indices
Sensex
71,924.68 -547.65
( -0.76%)
Global Indices
Nasdaq
51,671.07 418.43
(0.82%)
Dow Jones
7,831.57 45.21
(0.58%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,644.02 91.97
(0.87%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

Shree Ganesh Biotech India Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
539470
INE051N01026
1.5963264
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
18.74
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

trf ltd
Barak Valley Cements consolidated net profit rises 22.88% in the March 2026 quarter
May 28,2026
Net profit of Barak Valley Cements rose 22.88% to Rs 1.45 crore in the quarter ended March 2026 as against Rs 1.18 crore during the previous quarter ended March 2025. Sales rose 2.92% to Rs 59.65 crore in the quarter ended March 2026 as against Rs 57.96 crore during the previous quarter ended March 2025.

For the full year,net profit declined 94.39% to Rs 0.29 crore in the year ended March 2026 as against Rs 5.17 crore during the previous year ended March 2025. Sales rose 2.04% to Rs 212.17 crore in the year ended March 2026 as against Rs 207.93 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales59.6557.96 3 212.17207.93 2
OPM %5.987.44 -5.159.39 -
PBDT3.573.69 -3 8.1714.98 -45
PBT2.152.19 -2 2.799.06 -69
NP1.451.18 23 0.295.17 -94